FDA’s drug pro­mo­tion watch­dog plans study around ad­her­ence claims in phar­ma ads

The FDA wants to know if drug ad­ver­tise­ments with ad­her­ence claims in­flu­ence con­sumer and physi­cian opin­ions of pre­scrip­tion prod­ucts. It’s propos­ing the “Ad­her­ence Po­ten­tial and …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER